Application

16396352 · COMPOSITIONS COMPRISING A P75 TUMOR NECROSIS FACTOR RECEPTOR/IG FUSION PROTEIN

Filed 2019-04-26 · Granted · Patent 11104714 (2021-08-31) The official file ↗The patent and its PDF ↗ · Art unit 1646 · Examiner Ruixiang Li Typical · CPC A61K 47/183 · IMMUNEX CORPORATION · Marshall, Gerstein & Borun LLP (Amgen)

Office actions

first was Restriction requirement

RCEs

appealed

To first action

2.5 mo

to disposition 28.2 mo

Statutes raised

112

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.